Advisor Group Holdings, Inc. Synaptogenix, Inc. Transaction History

Advisor Group Holdings, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.23 - $0.4 $644 - $1,120	-2,800 Reduced 44.81%	3,448 $0
Q3 2023 Nov 13, 2023	SELL	$0.28 - $1.04 $364 - $1,352	-1,300 Reduced 17.22%	6,248 $2,000
Q2 2023 Aug 10, 2023	SELL	$0.78 - $1.0 $390 - $500	-500 Reduced 6.21%	7,548 $7,000
Q1 2023 May 12, 2023	SELL	$0.8 - $1.33 $880 - $1,463	-1,100 Reduced 12.02%	8,048 $6,000
Q4 2022 Feb 10, 2023	BUY	$1.02 - $181.75 $8,772 - $1.56 Million	8,600 Added 1569.34%	9,148 $10,000
Q2 2022 Aug 10, 2022	BUY	$3.88 - $7.41 $1,738 - $3,319	448 Added 448.0%	548 $3,000
Q1 2022 May 04, 2022	SELL	$6.31 - $10.09 $2,385 - $3,814	-378 Reduced 79.08%	100 $1,000
Q3 2021 Nov 05, 2021	BUY	$6.65 - $12.1 $33 - $60	5 Added 1.06%	478 $5,000
Q2 2021 Aug 02, 2021	BUY	$5.12 - $11.13 $2,421 - $5,264	473 New	473 $5,000

30K

Ticker SNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 6,840,630
Market Cap $21M
Description
Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodeg...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.